Disease: Leishmaniasis, Visceral ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023290
Disease: Leishmaniasis, Visceral
Leishmaniasis, Visceral 		0.020 Biomarker disease BEFREE Herein, we evaluated the treatment strategy employing a therapeutic heterologous vaccine composed of antigens of <i>Leishmania braziliensis</i> associated with MPL adjuvant (LBMPL vaccine) for visceral leishmaniasis (VL) in symptomatic dogs naturally infected by <i>Leishmania infantum</i>. 28321217 2017
CUI: C0023290
Disease: Leishmaniasis, Visceral
Leishmaniasis, Visceral 		0.020 Biomarker disease BEFREE Our results define the immunopotentiating effect of MPL-TDM on protein Ag encapsulated in a controlled release system against experimental VL. 22206029 2011